Central retinal artery occlusion is an ophthalmologic emergency and an important cause of acquired blindness. Occlusion of the central retinal artery is usually secondary to one or more serious systemic...
Schrag Lab
Our mission – cure CAA
Cure Cerebral Amyloid Angiopathy
This page is meant to be a resource for our patients and anyone living with CAA or caring for someone with CAA. CAA is a terrible disease that causes memory and cognitive loss and intracerebral haemorrhage. Curing CAA would be a victory, not only for our patients but also in the fight against Alzheimer’s disease and dementia.
Meet the Team
Matthew Schrag, PhD
Principle investigator
Alena Kozunda
Lab manager
Wilber Fernandez, PhD
Staff scientist
Lissa Ventura Antunes
Staff scientist
Elena Solopova
Undergrad student
RECENT BLOG POSTS
Virtually all clinical trials of Alzheimer’s medications have failed in the last 15 years. Drugs ranging from antibodies to neurochemical enhancers did not make it to the pharmacies. However, plenty...
The FDA conditionally approved Biogen’s drug aducanumab for Alzheimer’s disease yesterday, the first new treatment for this disease approved in decades. As a physician caring for patients with Alzheimer’s disease,...
Last week the Alzheimer’s Association appealed to the FDA to approve Biogen’s anti-amyloid immunotherapy drug aducanumab after the FDA heard appeals from patients and families affected by this Alzheimer’s disease....